Sign in

Benjamin L. Palleiko

Chief Executive Officer at KalVista Pharmaceuticals
Since March 7, 2024
Age
59 years
Education
Holds a B.A. in Quantitative Economics from Tufts University and an M.B.A. in Finance along with an M.A. in International Relations from the University of Chicago.
Tenure
Joined KALV in August 2016 as Chief Financial Officer, later taking on the role of Chief Business Officer in March 2019, being promoted to President in January 2023, and ultimately appointed as Chief Executive Officer in March 2024.

Also at KalVista Pharmaceuticals

BP
Brian Piekos
Chief Financial Officer
CMY
Christopher M. Yea
Chief Development Officer
JL
Jeb Ledell
Chief Operating Officer

About

Benjamin L. Palleiko is a seasoned executive with a diverse background in both financial management and operational leadership. Before his tenure at KALV, he developed a robust foundation through various roles in the pharmaceutical and financial sectors, including serving as the co-Founder and Chief Executive Officer of Cielo Therapeutics, Inc. and working as an investment banker with Robertson Stephens and SunTrust Bank.

His career at KALV began when he joined as the Chief Financial Officer in August 2016, and he quickly advanced within the organization. Over time, he was entrusted with greater responsibilities, serving as the Chief Business Officer starting in March 2019, and later as President in January 2023. His steady rise through these ranks is a testament to his leadership and strategic acumen.

In addition to his executive roles, Palleiko also brings a strong educational background and military discipline to his work. With degrees in economics, finance, and international relations, and having served as a Naval Aviator in the U.S. Navy, he combines academic excellence with real-world experience. His contributions to KALV have been pivotal in driving growth and preparing the company for regulatory milestones, reflecting a well-rounded blend of strategic vision and operational expertise.

$KALV Performance Under Benjamin L. Palleiko

Past Roles

OrganizationRoleDate RangeDetails
KalVista Pharmaceuticals (KALV) President January 2023 – March 2024 Promoted to President prior to becoming CEO
KalVista Pharmaceuticals (KALV) Chief Business Officer March 2019 – January 2023 Held dual responsibilities; later succeeded by promotion
KalVista Pharmaceuticals (KALV) Chief Financial Officer August 2016 – March 2019 Joined as CFO and later added additional roles
Cielo Therapeutics, Inc. Co-Founder and Chief Executive Officer 2012 – June 2016 Co-founded and led the company
Ore Pharmaceutical Holdings Inc. Senior Vice President and Chief Financial Officer N/ANo specific tenure provided
Penwest Pharmaceuticals Co. Senior Vice President and Chief Financial Officer N/ANo specific tenure provided
Robertson Stephens Investment Banker N/ANo additional details available
SunTrust Bank Investment Banker N/ANo additional details available
U.S. Navy Naval Aviator N/AEarly career military service

Fixed Compensation

Data from  FY 2024
Component NameAmountPayment ScheduleAdditional Details
Salary$580,441 Annual Fixed annual salary
All Other Compensation$13,491 Annual Company contributions to the 401(k) Plan

Performance Compensation

Data from  FY 2024

No information available on performance compensation for 2024